Laminins are large, complex, protein molecules that
reside in the basal lamina and play a critical role in
tissue development and regeneration. Currently, 12
distinct laminin molecules have been identified, and
many more are expected to exist. Their usefulness
as potential therapeutic agents has not been realized.
We believe, because a viable method for their production
was not available. The Company's scientists have developed advanced recombinant
technology for the production of human laminin molecules, and three
have been developed to date; r-laminin-2, r-laminin-5
and r-laminin-8. They represent a promising new class
of regenerative medicines, and are currently being
evaluated for the treatment of periodontal, vascular,
and skin diseases.
More on Recombinant Laminin